Picture of OptimizeRx logo

OPRX — OptimizeRx News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousSmall CapSuper Stock

Optimizerx Corp Expected To Post A Loss Of 8 Cents A Share: Earnings Preview

* OPTIMIZERx Corp  OPRX.OQ   OPRX.O  is expected to show a
fall in
quarterly revenue when it reports  results on May 10. 
    * The Rochester Michigan-based  company is expected to
report  a
10.0% decrease in revenue to $12.355 million from $13.73 million
a year ago, according to the mean estimate from 7 analysts,
based on Refinitiv data. The company's guidance on March 8 2023,
for the period ended March 31, was for revenue between $11.50
million and $13.00 million.
    * ​Refinitiv's mean analyst estimate for OPTIMIZERx Corp is
for a
loss of 8 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for OPTIMIZERx
Corp
is $18​, above​ its last closing price of $14.54. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  0.25        0.24       0.25      Beat    3.6
 Sep. 30 2022  0.03        0.04       0.07      Beat    90.7
 Jun. 30 2022  0.09        0.09       0.04      Missed  -55.3​
 Mar. 31 2022  -0.03       -0.01      -0.01     Met     15.3
 ​​Dec.        0.22        0.21       0.22      Beat    7.3
 31 2021                                                
 Sep. 30 2021  0.13        0.13       0.09      Missed  -31.8​
 Jun. 30 2021  0.07        0.07       0.10      Beat    38.9
 Mar. 31 2021  -0.01       0.01       0.03      Beat    275
 This summary was machine generated May 8 at 22:47 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on OptimizeRx

See all news